Global Lung Cancer Surgery Market Insights Forecasts to 2033

• The Global Lung Cancer Surgery Market Size was Valued at USD 5.91 Billion in 2023
• The Market Size is Growing at a CAGR of 5.32% from 2023 to 2033
• The Worldwide Lung Cancer Surgery Market Size is Expected to Reach USD 9.92 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

 

Get more details on this report -

Request Free Sample PDF

The Global Lung Cancer Surgery Market Size is Anticipated to Exceed USD 9.92 Billion by 2033, Growing at a CAGR of 5.32% from 2023 to 2033.

 

Market Overview

Lung cancer surgery is an option for certain patients depending on the location, type, and stage of the patient’s lung cancer and other medical situations. Efforts to cure lung cancer with surgery include removing the tumor along with nearly all surrounding lung tissue and often lymph nodes in the area of the tumor. Eliminating the tumor with lung cancer surgery is considered the best choice when the cancer is limited and improbable to have spread. This involves early-stage non-small cell lung and carcinoid tumors. The main causes of lung cancer are excessive development of abnormal cancerous cells in the lung surface, factors, like smoking, inert smoking in a few cases, and contact with carcinogenic toxins and gases. There are main two types of approaches used to remove a part of the lung, including thoracotomy and minimally invasive surgery. The option depends on the size, location, and stage of the tumor and the expertise of the surgeon. In lung cancer surgery, different types of surgeries are used, such as lobectomy, segmentectomy, wedge resection, and pneumonectomy. Every type of lung cancer surgery option has likely side effects, like pain and probable complications from the lung cancer surgery. Advancements in surgical technologies, like minimally invasive surgical techniques, are making lung cancer surgeries harmless, more effective, and less distressing. The global market is growing as a result of improved patient demand for care in the early stages of the disease when surgical involvement is most effective.

 

Report Coverage

This research report categorizes the market for the global lung cancer surgery market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global lung cancer surgery market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global lung cancer surgery market.

 

Driving Factors

The increasing rate of lung cancer worldwide has been a key driver of the lung cancer surgery market. The demand for surgical interventions, such as minimally invasive techniques and traditional open surgeries increases as the number of diagnosed patients grows. Furthermore, rising product promotions are anticipated to drive the growth of the market during the predicted timeframe. In addition, early recognition of lung cancer has developed a significance for improving patient survival rates. Surgical involvement, frequently combined with other treatment modes like chemotherapy and radiation therapy, is a serious component of healing intent for early-stage lung cancer. Moreover, the rising acquisition of inorganic growth policies, like firms by the key players in the market is anticipated to drive the growth of the market over the predicted timeframe.

 

Restraining Factors

The high expenses lay the surgery out of reach for several patients without appropriate health insurance. Sometimes patients find themselves incapable of paying high co-pay necessities, even for those who have insurance. Additionally, post-lung cancer surgery difficulties existing a substantial challenge for the growth of the global lung cancer surgery market. Lung cancer surgery frequently has the risk of problems owing to the complicated anatomical location and structures of the lungs. Furthermore, the lack of awareness regarding lung cancer and its treatment choices in emergent areas is notably restraining the growth of the lung cancer market. In numerous undeveloped areas of the world, there is limited knowledge related to lung cancer and its symptoms in the general population also in healthcare professionals.  This is mainly because of the absence of patient training programs and resources to spread information regarding such a serious disease. People in rural and distant areas persist highly uneducated regarding the early signs and risk issues of lung cancer. As a result, maximum cases go undiagnosed till they spread to advanced stages, reducing the probability of effective surgery.

 

Market Segmentation

The global lung cancer surgery market share is classified into device, procedure, and end-users.

 

• The surgical instruments segment is anticipated to hold the largest share of the global lung cancer surgery market during the forecast period.    

On the basis of the device, the global lung cancer surgery market is divided into surgical instruments, monitoring & visualizing systems, and endosurgical equipment. Among these, the surgical instruments segment is anticipated to hold the largest share of the global lung cancer surgery market during the forecast period. Surgical instruments are essential apparatuses used throughout lung cancer surgeries for several procedures, like the removal of tumors, tissue separation, and suturing. Surgical instruments are mainly used for various types of lung cancer surgeries, such as lobectomy, wedge resection, and pneumonectomy. The governance of this segment can be credited to the constant advancements in surgical instrument technologies, allowing accurate and minimally invasive procedures. In addition, the rising incidence of lung cancer and the growing demand for surgical interferences contribute to the supremacy of the segment.

 

• The minimally invasive surgeries segment is anticipated to hold the highest share of the global lung cancer surgery market during the forecast period.

On the basis of the procedure, the global lung cancer surgery market is divided into thoracotomy and minimally invasive surgeries. Among these, the minimally invasive surgeries segment is anticipated to hold the highest share of the global lung cancer surgery market during the forecast period. Minor incisions and the less invasive nature of this technique result in uncomplicated patients and a quicker recovery time. Patients can reoccurrence to their normal activities as soon and experience less uneasiness during the healing progression. Minimally invasive surgery has compacted the risk of postoperative difficulties. There is a low risk of infection and wound difficulties meanwhile the incisions are minor. In addition, loss of blood is often significantly a lesser amount of with minimally invasive surgery.

 

• The hospitals segment is anticipated to hold the highest share of the global lung cancer surgery market during the forecast period.

On the basis of the end-users, the global lung cancer surgery market is divided into hospitals and ambulatory surgery centers. Among these, the hospitals segment is anticipated to hold the highest share of the global lung cancer surgery market during the forecast period. Hospitals have conventionally been the main setting for lung cancer surgeries due to their complete organization, advanced facilities, and the accessibility of a multidisciplinary team of healthcare specialists. Hospitals provide a huge range of services, such as diagnostic imaging, preoperative assessments, surgical measures, postoperative care, and follow-up services. Hospitals are well-equipped with advanced operating rooms, intensive care units, and dedicated lung cancer treatment units, allowing the facility of specialized care to patients.

 

Regional Segment Analysis of the Global Lung Cancer Surgery Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the global lung cancer surgery market over the predicted timeframe.

 

Get more details on this report -

Request Free Sample PDF

North America is anticipated to hold the largest share of the global lung cancer surgery market over the predicted timeframe. North America has well-developed healthcare facilities, advanced surgical services, and a high incidence of lung cancer cases. Furthermore, there is a robust prominence on early detection, effective treatment choices, and promising compensation policies, causal to the domination of North America in the market. North America, particularly the U.S. and Canada, has well-developed healthcare systems and access to advanced surgical techniques. There has been a strong prominence on minimally invasive surgeries, like video-assisted thoracoscopic surgery (VATS) and robotic-assisted surgeries, which lead to earlier recovery times and minimized post-operative difficulties. Personalized therapy options have been the focus of research and development activities in this region to improve patient outcomes. These factors expand the lung cancer surgery market over the predicted timeframe.

 

Asia-Pacific is anticipated to grow at the fastest rate in the global lung cancer surgery market over the predicted timeframe. Factors propelling the fast growth in the Asia Pacific region involve, the increasing cases of lung cancer, rising awareness regarding early diagnosis and treatment, enhancing healthcare facilities, and rising healthcare funding. Countries like India, Japan, and China are observing substantial developments in lung cancer surgery, with an effort to accept advanced surgical techniques and technologies. In addition, the existence of a large patient pool, a rising geriatric population, and growing funds in healthcare contribute to the fast growth of the Asia Pacific market. These factors drive the growth of the global lung cancer surgery market over the predicted timeframe.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global lung cancer surgery market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Johnson & Johnson
• Ethicon
• Karl Storz SE & Co. KG
• Medrobotics Corporation
• Accuray Incorporated
• Novartis AG
• Boston Scientific Corporation
• AngioDynamics
• Becton, Dickinson and Company
• Stryker Corporation
• Olympus Corporation
• Teleflex Incorporated
• Siemens Healthineers AG
• GE Healthcare
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Recent Developments

 

• In February 2023, Auris Health Inc., a manufacturer of medical devices, was purchased by Intuitive Surgical Inc., a company that designs, manufactures, and distributes products that help doctors and healthcare professionals. Auris Health is a company that develops bronchoscopy systems with robotic assistance. Intuitive Surgical has a new platform to develop robotically-assisted lung cancer surgery devices with the acquisition of Auris Health. 

 

• In May 2022, the BF-UC190F endobronchial ultrasound (EBUS) bronchoscope was introduced by Olympus Corporation, a producer of optical and digital precision technologies. A new generation of EBUS bronchoscopes with enhanced picture quality and navigation is the BF-UC190F. It is intended to aid surgeons in more accurately observing and biopsy lung cancerous tumors.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global lung cancer surgery market based on the below-mentioned segments: 

 

Global Lung Cancer Surgery Market, By Device

• Surgical Instruments
• Monitoring & Visualizing Systems
• Endosurgical Equipment

 

Global Lung Cancer Surgery Market, By Procedure

• Thoracotomy
• Minimally Invasive Surgeries

 

Global Lung Cancer Surgery Market, By End-User

• Hospitals
• Ambulatory Surgery Centers

 

Global Lung Cancer Surgery Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa